Cannabis for dyskinesia in Parkinson disease
Camille Carroll, Peter G. Bain, L. Teare, X. Liu et autres
BACKGROUND: The long-term treatment of Parkinson disease (PD) may be complicated by the development of levodopa-induced dyskinesia. Clinical and animal model data support the view that modulation of cannabinoid function may exert an antidyskinetic effect. The authors conducted a randomized, double-blind, placebo-controlled …
gb (code pays fourni par la source)
285 citations
Neurology